InvestorsHub Logo

BottomBounce

12/11/19 8:27 PM

#5554 RE: Value_Investor #5553

$BNGO Dr. from the MD Anderson Cancer Center demonstrated 100% concordance between data generated with Saphyr and structural variant data generated with “gold standard” cytogenetic methods in five bone marrow specimens with hematological malignancies. All previously identified cytogenetic abnormalities detected by karyotyping, FISH or microarray analysis were detected by Saphyr. In addition, several novel structural and copy number changes were detected. http://www.globenewswire.com/news-release/2019/10/24/1934941/0/en/Takeaways-from-ASHG-2019-in-Houston-Users-of-Bionano-s-Saphyr-System-Presented-Validation-Results-for-FSHD-Repeat-Expansion-Disorders-and-Digital-Cytogenetics-Among-a-Growing-List-.html


https://bionanogenomics.com/wp-content/uploads/2019/09/Bionano-Genomics-GenomeWeb-Dr-Jim-Broach-Webinar-White-Paper_0919.pdf